Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Aplastic × Mycophenolic Acid × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Myelodysplastic Syndromes 9 Hematologic Neoplasms 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Anemia, Refractory, with Excess of Blasts 5 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Hodgkin Disease 4 Hematologic Diseases 4 Myeloproliferative Disorders 3 Lymphoproliferative Disorders 3 Lymphoma, Mantle-Cell 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, B-Cell 3 Graft vs Host Disease 3 Primary Myelofibrosis 2 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphatic Diseases 2 Leukemia, Prolymphocytic 2 Leukemia, Myeloid 2

Interventions

Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Antiviral Agents 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡